Literature DB >> 11113915

Prenatal MRI in a fetus with a giant neck hemangioma: a case report.

H Shiraishi1, M Nakamura, K Ichihashi, A Uchida, A Izumi, H Hyodoh, M Y Momoi.   

Abstract

We report a fetus with a giant neck hemangioma which was examined by MRI in utero. The initial diagnosis was made by ultrasonography. The sonolucent aspect of the mass, together with the presence of pulsating Doppler flow signals, was highly suggestive of a fetal hemangioma. In late pregnancy, fetal MRI revealed the location, size and characteristics of the neck tumor. Following prenatal corticosteroid treatment and premature delivery of the pregnancy due to fetal cardiac failure, the newborn received angiography and coil embolization of the tumor vessels. Despite vigorous treatments, the newborn died 12 h after birth. Evaluation of a fetal neck hemangioma by MRI is recommended late in pregnancy for precise information on the tumor and adjacent organs since the image is valuable for planning optimal perinatal treatment. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11113915     DOI: 10.1002/1097-0223(200012)20:12<1004::aid-pd953>3.0.co;2-z

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Prenatal MRI of neck masses with special focus on the evaluation of foetal airway.

Authors:  Anna Ravelli; Marcello Napolitano; Mariangela Rustico; Giovanna Riccipetitoni; Giovanni Di Leo; Andrea Righini; Francesco Sardanelli
Journal:  Radiol Med       Date:  2019-06-07       Impact factor: 3.469

2.  Neonatal Airway Compromise by a Giant Cervicothoracic Venous Haemangioma.

Authors:  Janardhan Shenoy; Anita Coutinho; Sowmini P Kamath; Suresh Pai; Santosh Pv Rai
Journal:  J Clin Diagn Res       Date:  2017-02-01

3.  Case report: Ultrasound-guided intrauterine biopsy and RF ablation therapy for fetal posterior neck solid tumor: first successful report.

Authors:  Shanshan Liu; Qiong Luo; Xiaofeng Fu; Minyan Wang; Qingguo Zou; Licheng Wang; Guangjuan Kan; Xing Si; Heqin Dong; Xiani Lan; Yutian Han; Jiang Zhu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.